现代诊断与治疗
現代診斷與治療
현대진단여치료
MODERN DIAGNOSIS AND TREATMENT
2014年
14期
3124-3126
,共3页
祝林%曾宏%余帮龙%母其文
祝林%曾宏%餘幫龍%母其文
축림%증굉%여방룡%모기문
溶栓%组织型纤溶酶原激活物%磁共振成像%弥散
溶栓%組織型纖溶酶原激活物%磁共振成像%瀰散
용전%조직형섬용매원격활물%자공진성상%미산
Thrombolysis%Tissue-type plasminogen activator%Magnetic resonance imaging%Diffusion
目的:探讨溶栓治疗在存在缺血半暗带的急性脑梗塞于超时间窗(>4.5h)应用的价值。方法选择在发病12h内,且磁共振检查发现具有半暗带证据,即灌注成像-弥散成像不匹配,(PWI-DWI)/DWI%>20%的48例急性脑梗塞患者分为溶栓组和对照组,溶检组给予重组组织型纤溶酶原激活剂(rt-PA)0.6~0.9mg/kg静脉溶栓治疗及溶栓治疗,对照组只做常规治疗。两组患者在溶检前和溶栓后2w、3个月分别行美国国立卫生院卒中量表(NIHSS)评分和日常生活能力量表(ADL)评分。结果溶栓组在溶栓后2w、3个月NIHSS评分均较对照组降低(P<0.01);ADL评分较对照组明显升高(P<0.01)。结论对存在半暗带的急性脑梗塞,适当延长溶检时间窗可减小最终的梗塞面积,改善患者预后,提高患者生活质量。
目的:探討溶栓治療在存在缺血半暗帶的急性腦梗塞于超時間窗(>4.5h)應用的價值。方法選擇在髮病12h內,且磁共振檢查髮現具有半暗帶證據,即灌註成像-瀰散成像不匹配,(PWI-DWI)/DWI%>20%的48例急性腦梗塞患者分為溶栓組和對照組,溶檢組給予重組組織型纖溶酶原激活劑(rt-PA)0.6~0.9mg/kg靜脈溶栓治療及溶栓治療,對照組隻做常規治療。兩組患者在溶檢前和溶栓後2w、3箇月分彆行美國國立衛生院卒中量錶(NIHSS)評分和日常生活能力量錶(ADL)評分。結果溶栓組在溶栓後2w、3箇月NIHSS評分均較對照組降低(P<0.01);ADL評分較對照組明顯升高(P<0.01)。結論對存在半暗帶的急性腦梗塞,適噹延長溶檢時間窗可減小最終的梗塞麵積,改善患者預後,提高患者生活質量。
목적:탐토용전치료재존재결혈반암대적급성뇌경새우초시간창(>4.5h)응용적개치。방법선택재발병12h내,차자공진검사발현구유반암대증거,즉관주성상-미산성상불필배,(PWI-DWI)/DWI%>20%적48례급성뇌경새환자분위용전조화대조조,용검조급여중조조직형섬용매원격활제(rt-PA)0.6~0.9mg/kg정맥용전치료급용전치료,대조조지주상규치료。량조환자재용검전화용전후2w、3개월분별행미국국립위생원졸중량표(NIHSS)평분화일상생활능역량표(ADL)평분。결과용전조재용전후2w、3개월NIHSS평분균교대조조강저(P<0.01);ADL평분교대조조명현승고(P<0.01)。결론대존재반암대적급성뇌경새,괄당연장용검시간창가감소최종적경새면적,개선환자예후,제고환자생활질량。
Objective To explore the value of thrombolytic therapy with broadened therapeutic window(>4.5h) in patients with acute cerebral infarcts, with magnetic resonance perfusion-weighted imaging(PWI)-diffusion-weighted imaging(DWI) mismatch. Methods 48 patients with acute cerebral infarcts who were imaged by magnetic resonanceand (PWI-DWI)/DWI>20% within 12 hours after symptom onset were divided into thromobolytic group and control group.The patients in thro-mobolytic group were treated with intravenous rt-PA(0.6~0.9mg/kg) and common therapy, the con-trols were received common therapy. The two groups were scored with national institutes of health stroke scale (NIHSS)/activities of daily living (ADL) score respectively at pre-thrombolysis, 2W and 3M after thrombolysis. Results The NIHSS score of the thromobolytic group at 2W and 3M after thrombolysis was lower than that of the control group(P<0.01), the ADL score of the thromobolytic group at 2W and 3M afrer thrombolysis was higher than that of the control group significantly(P<0.01).Conclusion Thrombolytic therapy beyond the time window (>4.5h) in patients with acute cerebral infarcts,with magnetic resonance perfusion-weighted imaging (PWI)-diffusion-weighted imag-ing(DWI) mismatch, is beneficial and feasible.